img

ESC 2022

Here are the most important scientific articles of the ESC 2022 Congress.

If you cannot view the articles, click here

ESC 2022

ESC 2022 | INVICTUS and PRE18FFIR
On the 3erd day of the European Cardiology Congress 2022 the INVICTUS study was presented, including 4565 patients with atrial fibrillation secondary to rheumatism driven CAD. The aim of ...

ESC 2022

ESC 2022 | PERSPECTIVE: Efficacy and Safety of Sacubitril/Valsartan Compared with Valsartan in Cognitive Function of Patients with Cardiac Failure and Preserved Function
About 30 to 80% of patients with heart failure (HF) have some sort of cognitive impairment, with a higher risk of dementia than the general population.  A ...

ESC 2022

ESC 2022 | SECURE Trial
This study, presented by Dr. Valentin Fuster , focused on the importance of medical treatment compliance, initially showing data from the FOCUS study where the poor compliance observed in ...

ESC 2022

ESC 2022 | TIME STUDY
The TIME study , presented by Dr. Thomas MacDonald, is a randomized study of over 21,000 patients with high blood pressure with a follow-up beyond 5 years. As ...

ESC 2022

ESC 2022 | Should We Follow-Up with Functional Testing in High-Risk Patients after CTA?
While the need for repeat cinecoronary angiography after transluminal coronary angioplasty (TCA) has decreased with the use of drug-eluting stents and improved medical treatment, patients still ...

ESC 2022

ESC 2022 | REVIVED-BCIS2
The REVIVED-BCI2 included 700 patients with ejection fraction ≤ 35% with extended coronary artery disease and plausible PCI. Patients were randomized to PCI ...

Top